A delta-based multi-omics model to predict adaptive radiotherapy benefit in patients with non-small cell lung cancer during carbon-ion radiotherapy
Open Access
- 24 April 2026
- journal article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Abstract
Objective. Patients with non-small cell lung cancer (NSCLC) treated with carbon-ion radiotherapy (CIRT) are potential candidates for adaptive radiotherapy (ART). However, ART is time- and resource-intensive. This study aimed to develop a decision-support tool to estimate ART demand before treatment. Approach. This retrospective study included 69 patients with NSCLC treated with CIRT. Baseline clinical characteristics, dose–volume histogram (DVH) parameters, and radiomic and dosiomic features from the plan-computed tomography (CT) (1–2 weeks before treatment) and confirm-CT (1–2 days before treatment) were collected, and relative change rates in features (ΔDVH, Δradiomics, and Δdosiomics) were calculated. Feature selection involved univariable testing, correlation analysis, least absolute shrinkage and selection operator regression, and stepwise regression with 1000 bootstrap resamples. A multivariable logistic regression model was constructed and validated using 200 iterations of five-fold cross-validation. Main Results. ART was triggered in 32 (46.4%) patients. A five-feature delta-omic model (one ΔDVH, two Δradiomic, and two Δdosiomic features) achieved a validated median area under the curve of 0.897 (interquartile range, 0.833–0.950) with good calibration. At a high-sensitivity threshold (0.11), the model identified all ART candidates while potentially reducing the frequency of weekly-CT evaluations in 21.4% of patients; at the maximum-Youden threshold (0.41), the median accuracy reached 78.6%, with up to 50.0% classified as low ART demand. Significance. A delta-omic model predicting ART demand in patients with NSCLC receiving CIRT was developed. The model may help optimize resource allocation and streamline ART workflows, although prospective validation in larger cohorts is warranted before widespread clinical adoption.Keywords
This publication has 39 references indexed in Scilit:
- Delta radiomics: an updated systematic reviewLa radiologia medica, 2024
- Adapt or Perish: Adaptive RT for NSCLCInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2024
- Adaptive carbon ion radiotherapy for locally advanced non‐small cell lung cancer: Organ‐sparing potential and target coverageMedical Physics, 2022
- Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG OncologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Delta-radiomics increases multicentre reproducibility: a phantom studyMedical Oncology, 2020
- Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organsRadiological Physics and Technology, 2013
- Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Use of Brier score to assess binary predictionsJournal of Clinical Epidemiology, 2010
- Consequences of Anatomic Changes and Respiratory Motion on Radiation Dose Distributions in Conformal Radiotherapy for Locally Advanced Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009